https://www.exsightventures.com/blog daily 0.75 2026-02-08 https://www.exsightventures.com/blog/a-rising-tide2025-2026 monthly 0.5 2026-02-08 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/4dd16a61-d69e-4da1-9d7e-8a3046497c46/Photo+by+%3Ca+href%3D%22https%3A%2F%2Funsplash.com%2F%40timmarshall%3Futm_source%3Dunsplash%26utm_medium%3Dreferral%26utm_content%3DcreditCopyText%22%3ETim+Marshall%3C%2Fa%3E+on+%3Ca+href%3D%22https%3A%2F%2Funsplash.com%2Fphotos%2Fperson-surfing-on-body-of-water-vn59e-3J2oo%3Futm_source%3Dunsplash%26utm_medium%3Dreferral%26utm_content%3DcreditCopyText%22%3EUnsplash%3C%2Fa%3E Blog - The Turning Tide: Positioning for the Next Wave of Vision Innovation - Make it stand out Photo by Tim Marshall on Unsplash‍ ‍ https://www.exsightventures.com/blog/defeyeingexpectexsight monthly 0.5 2026-02-08 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/35477ef7-132e-4ba2-a5f7-c1828220cbd1/ion-fet-QRawWgV6gmo-unsplash.jpg Blog - DefEYEing Expectations - Make it stand out Photo by Ion Fet on Unsplash ‍ https://www.exsightventures.com/blog/eye-opener-pod-by-exsightventures monthly 0.5 2025-10-06 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/c62c52f0-775a-47d1-a3d4-cebb20eedd0a/jonathan-velasquez-c1ZN57GfDB0-unsplash.jpg Blog - We’re Live: Launching the Eye Opener Pod - Make it stand out Photo by Jonathan Velasquez on Unsplash https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1759764392290-0B5JQN61JDCY6DF1O2JR/alexander-shatov-w-qqwn5O-4I-unsplash.jpg Blog - We’re Live: Launching the Eye Opener Pod - Listen on Spotify Alexander Shatov via Unsplash https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1759764706003-NVGCP7CTACO5A1KXVRAU/Screenshot+2025-10-06+at+11.31.26%E2%80%AFAM.png Blog - We’re Live: Launching the Eye Opener Pod - Listen on Apple Podcasts Photo: Primakov/Shutterstock https://www.exsightventures.com/blog/revmodrevopsisrev-16sep monthly 0.5 2025-10-06 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/2b9b45de-9b9d-4849-ad60-90caa186948e/testalize-me-igSTmAWAW3s-unsplash.jpg Blog - Revopsis and the RevMod Revolution - Make it stand out Photo by Testalize.me on Unsplash https://www.exsightventures.com/blog/2025-o-p-p monthly 0.5 2025-09-16 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/f93b6b9c-ff29-4c64-afe5-a03bf7271319/paul-skorupskas-7KLa-xLbSXA-unsplash.jpg Blog - Opportunity, Policy, and Paradox - Make it stand out Photo by Paul Skorupskas on Unsplash https://www.exsightventures.com/blog/promise-and-repurpose monthly 0.5 2025-05-31 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/48fd2584-341f-4840-91f3-33e22fbe3a39/danilo-alvesd-Y14ONzYtxb4-unsplash.jpg Blog - Promise and (Re)Purpose - Make it stand out Photo by danilo.alvesd on Unsplash https://www.exsightventures.com/blog/new-year-new-fund monthly 0.5 2025-03-15 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/670a4cf8-91a7-4486-b1da-65a87adfaac0/adrian-trinkaus-NTApDysDC0s-unsplash.jpg Blog - New Year, New Fund - Make it stand out Photo by Adrian Trinkaus on Unsplash https://www.exsightventures.com/blog/dr-uday-devgan-joins-exsight monthly 0.5 2024-03-13 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/615d3f0c-6268-46d3-87a2-1ee184c43d03/matteo-vistocco-Dph00R2SwFo-unsplash.jpg Blog - DR. UDAY DEVGAN JOINS EXSIGHT VENTURES - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/77c3896b-05d1-4e0d-a9ec-c0dfc31c8354/close-up+photo+Uday+Devgan+MD+copy+2.jpeg Blog - DR. UDAY DEVGAN JOINS EXSIGHT VENTURES Dr. Devgan’s leadership has led to him being named one of the top key opinion leaders in ophthalmology and he has taught ocular surgery in more than 60 countries to tens of thousands of fellow ophthalmologists. Dr. Devgan runs CataractCoach.com which has 2,000 teaching videos/articles and boasts 68,000 subscribers with more than 30 million views. He also developed an entire curriculum series, a free cataract surgery book, and now the top podcast in ophthalmology. He writes regular columns in multiple ophthalmic journals. His Back to Basics monthly feature in the journal Ocular Surgery News about the fundamentals of ophthalmic surgery has been distributed to 80,000 ophthalmologists worldwide for over 18 years. https://www.exsightventures.com/blog/looking-back-ois-xiii monthly 0.5 2024-03-13 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/9a702a06-eebb-4e60-a7e8-dfcc5a422701/hari-nandakumar-dsV4yvL5UJk-unsplash.jpg Blog - LOOKING BACK: OIS XIII - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.exsightventures.com/blog/2023-year-in-review monthly 0.5 2024-02-08 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/7b97427d-c02c-40a2-a55b-5308b6e3b49e/ian-schneider-PAykYb-8Er8-unsplash.jpg Blog - 2023 Year in Review - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.exsightventures.com/blog/5rimom66b5e7225a7rfj7heoccdwc2-7t8zm-z5hxk monthly 0.5 2023-11-02 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/de8c852f-533b-477d-827a-8dbd9556ff19/daniel-oberg-sEApBUS4fIk-unsplash.jpg Blog - EXSIGHT ADDS 60% TO FUND 3 INCLUDING A LEADING EYE CARE FOUNDATION - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.exsightventures.com/blog/5rimom66b5e7225a7rfj7heoccdwc2-7t8zm monthly 0.5 2023-11-02 https://www.exsightventures.com/blog/dtx-acquired-sd-gdyy7-prw2g-398k5 monthly 0.5 2023-08-23 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/f7fb2623-d5e7-461c-b5d8-ead231c41bff/alan-mersom-NzkjR1pw0Lc-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Make it stand out Photo by Alan Mersom on Unsplash https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/34a78def-8339-48dc-bf2f-23c3af285872/sergio-mena-ferreira-TD6La_2q4aw-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Sergio Mena Ferreira on Unsplash Deal Sourcing and Origination Venture capital is highly competitive, with many firms and investors actively seeking the best investment opportunities. VCs build deal flow through networking, industry event attendance, thought leadership, entrepreneur submissions, and relationships with other investors, accelerators, and incubators. Co-investor relationships can be fruitful, particularly when both parties have shared a previous co-investment. Each investment is a multi-dimensional, dynamic group of connections. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/a5ac1403-593c-4dd9-a9db-8d9eab301211/charlesdeluvio-Lks7vei-eAg-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by charlesdeluvio on Unsplash Initial Screening Even after a warm introduction from a knowledgeable contact and co-investor, VC firms conduct an initial screening to assess if the startup aligns with their investment thesis and criteria. This phase often involves quickly reviewing the business model, market potential, team, and other vital factors. Though we focus on early-stage ophthalmology, only some companies that fit that criterion pass our first review. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/265fd166-bf2c-45da-8b39-1962e36ec4d0/scott-graham-5fNmWej4tAA-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Scott Graham on Unsplash Due Diligence Due diligence is a comprehensive investigation into the startup's business, technology, market, financials, legal aspects, etc. Due diligence helps identify potential risks and opportunities associated with the investment. In the case of early-stage life science companies, there is typically only foundational science to analyze. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/5bf77eb4-3b68-4859-aa93-4e4bd9372a7d/markus-winkler-jF1CqFpE62k-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Markus Winkler on Unsplash Deal Structure and Terms The terms of the investment are negotiated and determined upon successful completion of the diligence process. These terms include the valuation of the company, the amount of funding to be provided, the portion of the company the VC is purchasing, and any additional terms such as board representation, liquidation preferences, and protective provisions. The investment round's lead investor negotiates these terms. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/c97c7f9e-c57e-4766-99b7-3e93fd352526/Screen+Shot+2023-08-22+at+3.54.35+PM.png Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Source: SVB.com, Healthcare Investments and Exits: Mid-Year 2023 Update Silicon Valley Bank's recent mid-year report tracked the Median Seed/Series A Valuations and Deal Size. The implication based on the H1 2023 median pre-money valuation of $12M with a deal size of $8M is that the company sold 60% of the equity in a Series A financing. SVB added, “Investors are looking for Series A candidates that can draw lines between palatable valuation, runway through meaningful inflection milestones, and realistic exit prospects that do not rely upon the IPO window opening in the next 12-18 months.” https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/158e358e-6540-4e32-b039-a0a7c1d126e2/matteo-vistocco-Dph00R2SwFo-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Matteo Vistocco on Unsplash Investment Committee Approval and Investment Venture capital firms typically have well-defined investment committee approval processes to ensure thorough evaluation and effective decision-making when considering potential investment opportunities. These processes can vary from firm to firm. The investment committee typically comprises senior partners or critical decision-makers within the venture capital firm. They review the investment proposal and engage in discussions about the opportunity. These discussions often involve critical questions, concerns, and potential challenges associated with the investment. The committee's role is to ensure that the proposed investment aligns with the firm's overall strategy and risk appetite. After thorough deliberation, the investment committee decides on whether to proceed with the investment. The decision could be an approval, rejection, or a request for further information. Committees base decisions on combinations of due diligence findings, strategic fit, risk assessment, potential return on investment, and overall alignment with the firm's portfolio and objectives. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/c277fec9-1196-4193-b5a8-d6085b92be2e/jonas-jacobsson-MLSS52p0ze4-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Jonas Jacobsson on Unsplash Post Investment Support Venture capital firms often have a post-investment monitoring process to actively support and advise a portfolio company after the investment. Support can involve regular updates, board representation, strategic guidance, and assistance overcoming challenges. VCs can play a crucial role in adding value to their portfolio companies beyond just providing capital. Their expertise, industry knowledge, network, and experience can significantly contribute to the growth and success of these companies. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/5bdfd485-5cc9-4ab8-91f4-e5d8a481c80c/tobias-tullius-4dKy7d3lkKM-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Tobias Tullius on Unsplash Monitoring and Reporting VC firms keep a close eye on the performance of their portfolio companies. Regular updates, financial reports, and meetings with the startup's management team help the VC firm assess the company's progress and make informed decisions about further funding or exits. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/6ad29734-7139-4c6a-b8a3-82e90f097c63/kent-banes--qCZyWrv7_s-unsplash.jpg Blog - DTx Pharma’s FALCON™ SOARS to NOVARTIS ACQUISITION - Photo by Kent Banes on Unsplash Exit Strategy VC firms typically aim to exit their investments within a specific timeframe, often through acquisitions by a larger company or an initial public offering (IPO). The acquisition/IPO price and ownership at exit directly impact the returns the VC firm receives from its investment. Consequently, firms look at development timelines and valuation during their due diligence process to ensure that their portfolio companies can meet their targeted investment returns both on time and in the face of increasing dilution with each financing. https://www.exsightventures.com/blog/2023ascrs-sd-gdyy7-prw2g monthly 0.5 2023-08-22 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/604d1d15-0047-4c73-97e1-1a588a473741/zane-persaud-5JEwPOAZo24-unsplash.jpg Blog - Reflections from San Diego - ASCRS 2023 Round-Up - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/966c0c98-2175-465e-b84d-08f0ac46aac4/LensGen-Logo-png.png Blog - Reflections from San Diego - ASCRS 2023 Round-Up - Make it stand out LensGen, Inc. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/83c8e1e9-11bf-4e91-839d-41c7e1bbda9b/trefoil-logo.png Blog - Reflections from San Diego - ASCRS 2023 Round-Up - Make it stand out Trefoil Therapeutics https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/7be9a1ff-98a1-43ad-a065-e95407601002/elios+image.png Blog - Reflections from San Diego - ASCRS 2023 Round-Up - Make it stand out Elios Vision https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/8f5ff0f8-18d8-449b-bbdd-b61de9100ba3/1683408144837.jpeg Blog - Reflections from San Diego - ASCRS 2023 Round-Up - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.exsightventures.com/blog/gr-dompe-gdyy7 monthly 0.5 2023-05-20 https://www.exsightventures.com/blog/onlsersc1 monthly 0.5 2023-03-09 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/64beb231-e9fc-4284-808f-06e4d3114285/ExSightVentures-95.jpg Blog - ONL Therapeutics Extends Runway Into Phase 2 - David Esposito, CEO ONL Therapeutics ONL Therapeutics David Esposito discussing ONL at ExSight's ASRS Reception. (New York City, 2022) Photo credit: Jenna @ Spilled Milk Creative https://www.exsightventures.com/blog/novai-r4wl4 monthly 0.5 2023-01-31 https://www.exsightventures.com/blog/revanaseriesa119 monthly 0.5 2023-01-31 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/d7444ce5-9417-4c5b-ae1b-9e28506e968f/Screen+Shot+2022-07-27+at+11.42.00+AM.jpg Blog - Re-Vana Hauls in $11.9M Series A - Make it stand out ExSight partners Firas, Michael, and James with Re-Vana’s CEO Michael O’Rourke after receiving the ‘Retina Innovation Award’ in Drug Delivery at the 2022 OIS Retina Summit. https://www.exsightventures.com/blog/envision-gdyy7 monthly 0.5 2022-11-30 https://www.exsightventures.com/blog/valitor-the-real-mvp monthly 0.5 2022-11-17 https://www.exsightventures.com/blog/introducing-the-exsight-ventures-syndicate-on-angellist-3lk4g monthly 0.5 2022-09-22 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663863838078-6GBWJVDPDC3UUPQP0ROA/Screen+Shot+2022-09-22+at+12.23.28+PM.png Blog - EXSIGHT VENTURES OPENS ANGELLIST SYNDICATE TO THE OIS COMMUNITY - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.exsightventures.com/blog/5rimom66b5e7225a7rfj7heoccdwc2 monthly 0.5 2023-09-12 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663774516219-Z5V1SO057X1NTY8LJFS6/Screen+Shot+2022-07-27+at+11.42.00+AM.png Blog - LOOKING BACK ON SUMMER 2022 Re-Vana’s CEO Michael O’Rourke is pictured with the ExSight Ventures team and the 2022 Retina Innovation Award. https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777061684-N5MRAYUV0JM8WUY3YTXB/ExSightVentures-47.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777560285-5ACWVTWU3DVQD6XJOVJ3/ExSightVentures-92.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777559633-FUPFTNGD33U8UDTJLZHK/ExSightVentures-98+%281%29.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777558308-I8KSZ30CJ3G8SB6JAUJT/ExSightVentures-124.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777558263-NZESDZBE0SN5XT0TNQM4/ExSightVentures-131.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777558910-KQAGX6TOGD6DPRTDL7VW/ExSightVentures-116.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777559669-RKJ0BNRB0Z0XLANOUKS5/ExSightVentures-100.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777558872-897JIX4NV0GR38HSJI9E/ExSightVentures-108.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663778136598-G2ETR671O0N4H557SBE8/ExSightVentures-1.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777564596-ZUK3053HKSXLAF8K4UI6/ExSightVentures-22.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777560968-8HFSJ2JS3LUB70YL1CT5/ExSightVentures-84.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777560422-IL7JAMYI35LCGEBUEH5Y/ExSightVentures-90.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777561116-EUBOGP9ZJXAI5U3A8BLM/ExSightVentures-80.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777561693-FUHB7K4X4Q0LBW7TBZYC/ExSightVentures-78+%281%29.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777562455-NTO2GYPSEJJ9TFBQ9RJ1/ExSightVentures-71.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777561811-ZN7DDYNVRIKZVOZYFHKQ/ExSightVentures-59+%281%29.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777563016-DY3ZNSC38CQ6JAW2AHX8/ExSightVentures-58+%281%29.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777563222-8017K891NX6YI56NP51L/ExSightVentures-46.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777563726-9TFF3PXIMAVLC4XZXF2E/ExSightVentures-34.jpg Blog - LOOKING BACK ON SUMMER 2022 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1663777563849-NESKI4R575PRMPPJ7BY0/ExSightVentures-29.jpg Blog - LOOKING BACK ON SUMMER 2022 https://www.exsightventures.com/blog/onward-onl-hits-milestones-and-achieves-tranche-2-funding-of-469-million-series-b monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/ois-year-in-review monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/congratulations-to-lensgen-team-on-this-significant-milestone-ide-approval-from-the-us-fda-to-begin-clinical-study monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/elt-sight-taking-minimally-invasive-glaucoma-surgery-to-new-heights monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/trefoil-profiled-in-ophthalmology-biopharma-dealmakers monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/dtx-soars-to-100-million-series-b-to-advance-falconplatform monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/wall-street-journal-covers-new-crop-of-venture-firms-including-exsight monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/re-vana-therapeutics-delivers-32-million-oversubscribed-round monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/envision-diagnostics-raises-series-a-round monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/exsight-announces-dtx-investment-to-enable-delivery-of-rna-therapeutics monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/electrifying-vision-announcing-our-investment-in-2c-tech monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/introducing-the-exsight-ventures-syndicate-on-angellist monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/lensgen-is-the-talk-of-the-town-ascrs-2019 monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/his-kind-of-town-firas-hosts-ois-tv-at-oisasrs-in-chicago monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/announcing-our-next-fund-proof-of-concept monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/trefoil-moves-closer-to-a-clinical-trial-announcing-our-follow-on-investment monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/quras-promise-enable-smarter-treatment-decisions-based-on-better-information monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/onl-therapeutics-is-pioneering-an-entirely-new-approach-to-preserving-sight-and-halting-vision-loss monthly 0.5 2025-01-08 https://www.exsightventures.com/blog/exsight-partner-alan-spiro-joins-innovative-odylia-therapeutics monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/lensgen-hitting-milestones-and-broadening-patent-protection monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/the-exsight-ventures-thesis monthly 0.5 2023-09-13 https://www.exsightventures.com/blog/dr-rahhal-co-authors-breakthrough-stem-cell-transplant-trial-targeting-vision-loss monthly 0.5 2022-08-29 https://www.exsightventures.com/blog/tag/Podcast monthly 0.5 https://www.exsightventures.com/disclaimer daily 0.75 2022-07-25 https://www.exsightventures.com/privacy daily 0.75 2022-07-30 https://www.exsightventures.com/learn daily 0.75 2022-09-07 https://www.exsightventures.com/meet-the-team daily 0.75 2022-08-02 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1662483392613-BJRSWM7ZM5USVF70SSCM/Rectangle+16.jpg https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659453712102-XFOZQE8Y8Q2ENHB2CCEE/Rectangle+18.jpg https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659453815969-VB8RDJNJT3E2ENQ68K5I/unsplash-image-TACdQo62To0.jpg https://www.exsightventures.com/terms daily 0.75 2022-07-30 https://www.exsightventures.com/home daily 1.0 2025-08-18 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659454859728-52YRCRRQ73XANYDCGQHO/image-asset.jpeg https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659455623618-Y86JAWACXWCD7F2I2C1L/unsplash-image-G1iYCeCW2EI.jpg https://www.exsightventures.com/portfolio daily 0.75 2024-07-16 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659460744019-SO2RBVJ5V9IRGFQ8KJAG/Logos-All-3.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659299955090-ZQ02V8T5Q5VWZCHGMWZ9/Logos-All-4.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/832c5bcc-1948-48ad-bdaa-01d9343782a3/logo+2_logo+black.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300069306-ATQB7553P1VKN21M6YI4/Logos-All-9.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1721162042846-LGNCGXMBW3GTPL05DW8Z/image-asset.jpeg https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300098444-6ZK8NG80LZ4HUMUPCGLU/Logos-All-8.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300512919-J7AY6IUK0MUG1JGJTVYZ/Logos-All-2.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1661805543705-U5ATB48NNCHCPWQ4OLHV/Envision+Logo+600dpi+On+White.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300486593-N1I29RM1OC0FERQ590UU/Logos-All-7.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300460902-PLW7J98Z8Q1V18LFZJ4K/Logos-All-1.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300542735-QSUZN60HC8ZKL4CGD8N0/Logos-All-10.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1721162042846-LGNCGXMBW3GTPL05DW8Z/image-asset.jpeg https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659300005453-VAS3H57F505OEKI7BYQK/Logos-All-6.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/21cd0295-185c-427f-a085-2cd56ca40f89/Screen+Shot+2024-07-10+at+2.50.21+PM.png https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/bc1ba29b-826c-453a-ad04-5f20c9175e07/Novai+Black+Logo.png https://www.exsightventures.com/contact daily 0.75 2022-07-30 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659457625942-OOT9DDVXBIDUNEVT4WBB/image-asset.jpeg https://www.exsightventures.com/uday daily 0.75 2024-02-22 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/1659457625942-OOT9DDVXBIDUNEVT4WBB/image-asset.jpeg https://www.exsightventures.com/talentnetwork daily 0.75 2025-08-25 https://images.squarespace-cdn.com/content/v1/62d9750f0c63324e6a36b8e2/3b76af55-e1c3-4026-990b-cca22619f166/matthew-waring-mdS647i6-ZM-unsplash.jpg